FINVX
Price
$16.68
Change
+$0.09 (+0.54%)
Updated
Dec 2 closing price
Net Assets
16.28B
GMOIX
Price
$34.63
Change
+$0.26 (+0.76%)
Updated
Dec 2 closing price
Net Assets
1.02B
Interact to see
Advertisement

FINVX vs GMOIX

Header iconFINVX vs GMOIX Comparison
Open Charts FINVX vs GMOIXBanner chart's image
Fidelity Series International Value
Price$16.68
Change+$0.09 (+0.54%)
VolumeN/A
Net Assets16.28B
GMO International Equity III
Price$34.63
Change+$0.26 (+0.76%)
VolumeN/A
Net Assets1.02B
FINVX vs GMOIX Comparison Chart in %
View a ticker or compare two or three
VS
FINVX vs. GMOIX commentary
Dec 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is FINVX is a Buy and GMOIX is a Hold.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
FINVX has more cash in the bank: 16.3B vs. GMOIX (1.02B). FINVX pays higher dividends than GMOIX: FINVX (3.34) vs GMOIX (2.59). FINVX was incepted earlier than GMOIX: FINVX (16 years) vs GMOIX (39 years). GMOIX (0.73) is less costly to investors than FINVX (0.01). GMOIX is a more actively managed with annual turnover of: 71.00 vs. FINVX (33.00). FINVX has a lower initial minimum investment than GMOIX: FINVX (0) vs GMOIX (35000000). GMOIX annual gain was more profitable for investors over the last year : 43.32 vs. FINVX (34.00). FINVX (97.54) and GMOIX (95.77) have equivalent 5 years return.
FINVXGMOIXFINVX / GMOIX
Total Expense Ratio0.010.691%
Annual Report Gross Expense Ratio0.010.731%
Fund Existence16 years39 years-
Gain YTD39.17839.323100%
Front LoadN/AN/A-
Min. Initial Investment035000000-
Min. Initial Investment IRAN/AN/A-
Net Assets16.3B1.02B1,604%
Annual Yield % from dividends3.342.59129%
Returns for 1 year34.0043.3278%
Returns for 3 years76.6787.8987%
Returns for 5 years97.5495.77102%
Returns for 10 years115.88153.0276%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
VEEV240.09-0.32
-0.13%
Veeva Systems
ABP6.42-0.07
-1.08%
Abpro Holdings Inc
NWE67.12-0.85
-1.25%
NorthWestern Energy Group
ESPR3.66-0.06
-1.61%
Esperion Therapeutics
IKT1.41-0.09
-6.00%
Inhibikase Therapeutics